DR. AMAR J. GAJJAR, MD

Plain English
This study looked at patient education materials (PEMs) used in neurosurgery to see if they were too hard to understand for the average American reader, who reads at about an eighth-grade level. Researchers found that existing materials were indeed too complex, scoring significantly higher on readability tests than the eighth-grade level. After using ChatGPT-4 to rewrite 25 of these materials, the new versions scored much better for readability, making them easier for patients to understand. Who this helps: This helps patients by providing them with clearer, more understandable information about their medical conditions.

Plain English
This study looked at how a new scoring system, called the CGARP score, can predict the outcomes for patients undergoing spine surgery, based on their frailty and nutritional status. Researchers analyzed data from over 360,000 patients and found that using the CGARP score improved predictions of serious issues after surgery, such as a patient's risk of dying (with a prediction accuracy of 88%) and needing to stay longer in the hospital. This matters because it helps doctors identify higher-risk patients, allowing for better treatment planning and support before surgery. Who this helps: This research assists doctors and healthcare teams in managing the care of patients who are at greater risk for complications after spine surgery.

Plain English
This study looked at how to better classify and treat children with medulloblastoma, a type of brain cancer, by analyzing data from three clinical trials involving 898 patients. The researchers found that no single treatment was better than others in terms of survival, but adding a drug called carboplatin to a specific high-dose radiation treatment improved survival for some patients. They created a new risk classification system to help doctors identify which patients can safely receive less toxic treatment while still improving their chances of survival. Who this helps: This helps patients with medulloblastoma and their doctors by providing a clearer approach to treatment.

Plain English
This study looked at two medications, tenecteplase (TNK) and alteplase (TPA), used to treat patients with a type of stroke called basilar artery occlusion before they receive a specific clot removal procedure. Among 163 patients, TNK led to a good functional outcome for 61.8% of patients, while TPA helped 48.8%. Both medications had similar rates of effectiveness and safety, so either option is viable for treating this serious stroke condition. Who this helps: This information benefits patients experiencing basilar artery occlusion and their doctors in choosing effective treatment options.

Plain English
This study compared two treatments, tenecteplase (TNK) and alteplase (TPA), for stroke patients with a blockage in the basilar artery. Researchers found that 51.7% of patients treated with TNK achieved quick and successful blood flow restoration after the first try, compared to just 32.9% of those treated with TPA. Since achieving this quick restoration is linked to better recovery over 90 days, the results suggest that TNK could be more effective than TPA for these patients. Who this helps: This benefits stroke patients and doctors by providing insights on more effective treatment options.

Plain English
This research focused on improving how doctors classify brain tumors by using a method based on DNA methylation, which looks at chemical changes in DNA. The study introduced a new version of a tool called the Heidelberg CNS Tumor Methylation Classifier, which now can identify 184 different tumor types, up from 91 previously. This tool is highly accurate, achieving a 95% success rate in identifying these subclasses, making it a more reliable way to help tailor treatment plans for patients. Who this helps: This benefits patients with central nervous system tumors by ensuring they receive more precise and personalized treatment options.

Plain English
Researchers studied rhabdoid tumors, aggressive cancers that primarily affect very young children, with survival rates under 30% in high-risk cases. They found that certain targets for new treatments, like DDB1-CUL4-associated factor 5 and MDM2, show promise, and developing drugs that can better attack these tumors while reducing side effects is crucial. This matters because current treatments are harsh and not very effective, so finding better therapies could significantly improve outcomes for these young patients. Who this helps: This helps young patients with rhabdoid tumors and their families.

Plain English
The study focused on a new method, called M-PACT, that uses tiny amounts of DNA from cerebrospinal fluid to identify different types of pediatric brain tumors. Researchers found that M-PACT could accurately classify these tumors with 92% accuracy in initial tests and 88% accuracy in further validation. This is important because it offers a more reliable way to diagnose brain tumors in children, which can lead to better treatment options. Who this helps: This helps pediatric patients with brain tumors and their doctors by providing a more effective diagnostic tool.

Plain English
This study looked at the long-term effects of posterior fossa syndrome in children who survived brain tumors called medulloblastomas. It found that survivors with this syndrome had significant difficulties in attention, processing speed, and physical performance, scoring lower in these areas than those without the syndrome—specifically, they were 8 times more likely to need help with everyday tasks. These results highlight the importance of better surgical techniques and ongoing support for survivors to improve their quality of life. Who this helps: Patients who have survived childhood medulloblastoma and their families.

Plain English
This study compared two tools used to measure frailty in patients before spinal surgery, specifically the Modified Frailty Index (mFI) and the Risk Analysis Index (RAI). The results showed that the RAI is better at predicting the risk of death within 30 days after surgery (82% accuracy) and major complications (69% accuracy), while both tools performed similarly in predicting whether patients would need to go to a care facility instead of returning home. These findings are important because choosing the right frailty assessment can help doctors better evaluate patient risks and improve surgical outcomes. Who this helps: This helps doctors making decisions about surgery for older patients.

Plain English
This study looked at how to measure two eye medications, lifitegrast and rebamipide, in contact lenses designed to treat dry eye disease. The researchers developed a reliable and simple method that showed both drugs can be effectively released from the lenses, with lifitegrast fully released in 5 hours and rebamipide in 7 hours. This is important because it could lead to better treatment options for dry eye patients, making medications more effective and easier to use. Who this helps: Patients with dry eye disease.

Plain English
This study looked at a type of childhood brain tumor called pineoblastoma, which has different kinds that respond differently to treatment. Researchers found that all the variations of this tumor share a common feature, known as the tumor-associated photoreceptor signature, which also appears in other brain cancers like retinoblastoma and certain medulloblastomas. Understanding these shared traits is important because it opens up new possibilities for treatment targeting the shared vulnerabilities among these tumors. Who this helps: This helps patients with these specific types of brain tumors and their doctors in finding better treatments.

Plain English
This study looked at how radiation therapy for children with medulloblastoma affects their thinking skills over time. It found that higher doses of radiation to certain areas of the brain, specifically the frontal lobe, led to a decline in processing speed by about 0.11 units each year for every additional gray of radiation received. Understanding which brain areas are more sensitive to radiation can help doctors adjust treatment plans to protect cognitive function in these young patients. Who this helps: This helps patients and their families by improving treatment strategies for better long-term cognitive health.

Plain English
This study looked at how home care services after spinal surgery (lumbar fusion) affected patients' health outcomes and hospital visits. It involved 758 patients, where 13.6% received home care. The results showed that those with home care had a higher chance of needing to return to the hospital (12.6% vs. 3.51%) or having to undergo more surgery (13.6% vs. 1.07%), and even tended to report worse health after six months compared to those without home care. Who this helps: This information is valuable for doctors and healthcare providers when deciding on post-surgery care for patients.

Plain English
This study looked at specific signs in brain scans, called the clot meniscus and claw signs, to see if they could predict how well patients with strokes would do after a minimally invasive procedure to remove blood clots. The researchers analyzed data from seven studies with over 1,500 patients. They found that while these signs did not affect the success of the procedure itself, patients with a positive clot meniscus or claw sign were more likely to have a better recovery. Who this helps: This helps patients who are undergoing treatment for ischemic strokes, as it may provide insights into the best techniques for their recovery.

Plain English
This study looked at the costs and trends of heart-related hospitalizations and procedures in the U.S. from 2016 to 2021. In 2021, there were nearly 4.7 million hospitalizations for heart issues, costing a total of $108 billion, with heart failure being the most expensive at about $18.5 billion. These findings highlight that heart disease is a significant financial burden on the healthcare system, with costs expected to rise to $131.3 billion by 2030. Who this helps: This information benefits patients and healthcare providers by highlighting the need for better management and prevention of cardiovascular diseases.

Plain English
This study focused on analyzing circulating tumor DNA (ctDNA) to improve the detection and monitoring of childhood cancers, particularly leukemias. Researchers tested blood samples from 233 children and found that 100% of those with blood cancers had detectable ctDNA, with 97% of expected tumor mutations identified. In contrast, ctDNA was only found in a small number of children with solid tumors and brain tumors. This research is important because it shows that ctDNA analysis can accurately find cancer mutations, allowing for better tracking of treatment responses and disease progression in young patients. Who this helps: This benefits children with cancers, their families, and healthcare providers.

Plain English
Researchers studied a combination treatment of a drug called veliparib, radiation, and chemotherapy (temozolomide) in children with high-grade glioma, a type of brain tumor. They found that among the 23 children treated, only 23% lived without disease progression after one year, while 64% survived overall. For a separate group of 14 children with a different tumor profile, 57% experienced no disease progression, and 93% were still alive after one year. These results matter because, although the treatment was safe and tolerable, it did not improve outcomes compared to previous treatments that used higher doses of chemotherapy. Who this helps: Patients with high-grade glioma and their families.

Plain English
This study looked at whether starting blood-thinning medications (anticoagulants) early or late after a stroke in patients with a heart condition called atrial fibrillation affects their chances of having more strokes, bleeding in the brain, or dying. The research combined data from seven studies and found no significant differences between patients who started anticoagulation early and those who started it late; both groups had similar rates of stroke (about 28%) and major bleeding events (about 1%). This is important because it helps doctors understand that the timing of starting these medications might not matter as much as previously thought, allowing for more flexible treatment plans. Who this helps: This helps patients recovering from strokes and their doctors by providing clearer guidelines for treatment timing.

Plain English
This study looked at the bacteria found in the red seaweed Gracilaria dura, which is important for industry. Researchers identified 75 different types of bacteria, with 21% showing the ability to fight off harmful pathogens. They found that most bacteria were in the Proteobacteria group, which plays a role in supporting seaweed growth and surviving tough conditions. Who this helps: This helps seaweed farmers and researchers focused on improving cultivation methods.

Plain English
This study looked at why some patients need to stay in the Intensive Care Unit (ICU) after receiving endovascular treatments for unruptured brain aneurysms. Out of 8,189 patients reviewed, 5,620, or about 24.6%, were admitted to the ICU. Key factors for ICU admission included the location of the aneurysm, related symptoms, and how long the procedure took, highlighting a need for better research to provide clearer guidelines for patient care. Who this helps: This information benefits doctors and healthcare teams treating patients with unruptured brain aneurysms.

Plain English
This study looked at how treatments for a type of brain cancer called medulloblastoma affect areas in the brain around small blood vessels, known as perivascular spaces (PVS), by analyzing 778 MRI scans from 241 young patients. The researchers found that PVS increased three months after patients received radiation therapy, then decreased after chemotherapy, only to rise again at follow-up. These findings are important because they help doctors understand how different treatments affect the brain over time, which can improve patient care. Who this helps: This helps patients and their doctors in planning and monitoring treatment for medulloblastoma.

Plain English
This study looked at the safety and effectiveness of weight loss surgeries, specifically for patients with severe obesity (classified as ASA IV status). Out of 131 patients, the surgery resulted in significant weight loss: the group that had biliopancreatic diversion lost an average of 39.5% of their total body weight after two years, followed by gastric bypass at 32.5% and sleeve gastrectomy at 20.7%. There were some complications, with 8.4% facing major issues within 30 days and 14.5% having complications beyond 90 days, but overall, the surgeries were found to be safe and beneficial. Who this helps: This helps patients with severe obesity looking for effective weight loss solutions.

Plain English
This research paper looks at how different weight loss surgeries and endoscopic treatments can help people with type 2 diabetes (T2D) reach remission—a state where diabetes symptoms significantly improve or disappear. It found that patients who had shorter diabetes duration and lower blood sugar levels before surgery had the best chances of remission, with surgical options like Roux-En-Y gastric bypass leading to higher success rates than sleeve gastrectomy. Understanding these factors is important because they can help doctors choose the best treatment for patients, potentially improving diabetes outcomes. Who this helps: This helps patients with type 2 diabetes and their doctors in making more informed treatment decisions.

Plain English
This study looked at brain development in young patients with medulloblastoma, a type of brain cancer, before they start additional treatments like radiation and chemotherapy. Researchers found that these patients had noticeable changes in brain structure: their brains showed increased diffusivity (meaning the movement of water in brain tissue was altered) and decreased thickness in several important regions, which are linked to functions like thinking and paying attention. These findings indicate that the effects of the tumor and surgery may harm brain development even before treatment begins, which could lead to challenges in cognitive abilities later on. Who this helps: This helps patients and their families understand the risks of cognitive decline after medulloblastoma treatment.

Plain English
This paper discusses guidelines for diagnosing and treating two serious types of brain cancers in children: diffuse high-grade gliomas and medulloblastomas. The guidelines are based on a review of various studies and expert discussions to ensure that children and teens receive the best care possible. This is important because it helps standardize treatment approaches, improving outcomes for young patients. Who this helps: Families with children diagnosed with brain cancer and the doctors treating them.

Plain English
This study looked at the medication entrectinib and its effectiveness and safety for children with specific types of tumors that have NTRK or ROS1 gene fusions. It found that 72.7% of young patients with NTRK fusions and 65.0% with ROS1 fusions showed significant tumor reduction after treatment, with responses occurring in about 1.9 months on average. Importantly, the treatment was generally safe, with the most common side effects being weight gain and anemia. Who this helps: This research benefits children with NTRK or ROS1 fusion-positive tumors and their healthcare providers.

Plain English
This study looked at how treatment for brain tumors in very young children can lead to hearing loss, and how that hearing loss affects their thinking and learning. Out of 135 children, 67% experienced some level of hearing loss, which was linked to a decline in IQ, lower adaptive functioning, and more attention problems over time. These results are important because they highlight the need for better treatment strategies and support for young patients to help protect their cognitive development. Who this helps: This helps young patients with brain tumors and their families, as well as healthcare providers and educators.

Plain English
This study looked at new types of weight loss surgeries, specifically one-anastomosis gastric bypass (OAGB), biliopancreatic diversion with duodenal switch (BPD-DS), and single-anastomosis duodenoileostomy with sleeve (SADI-S). These surgeries can lead to significant weight loss, especially for people with severe obesity, but they also carry risks of malnutrition. While the surgeries can be very effective, they require careful patient selection and long-term follow-up to prevent nutritional deficiencies. Who this helps: This helps patients with severe obesity considering weight loss surgery.

Plain English
This study looked at children under six years old who had a type of brain cancer called Sonic Hedgehog (SHH) medulloblastoma that came back after treatment. The researchers found that these patients had a 3-year survival rate of 61.6%, and those who received certain treatments like surgery or lower doses of radiation had better outcomes. This is important because it highlights the need for better initial treatments to prevent relapses and suggests alternative therapies that are less harmful for patients who do experience a relapse. Who this helps: This helps young patients with SHH medulloblastoma and their families.

Plain English
This study looked at the effectiveness and safety of a device called the Surpass Evolve Flow Diverter used to treat brain aneurysms. It found that after treatment, 67.1% of aneurysms were completely blocked, with complications occurring in about 18.2% of cases, mostly narrowing of the device. This matters because it shows that while the device can be effective, there are risks involved, particularly with larger aneurysms being harder to treat effectively. Who this helps: This benefits patients with brain aneurysms and their doctors by providing important information for treatment decisions.

Plain English
This study looked at how much neurosurgeons in the United States spend to be part of organized neurosurgery activities, like memberships, meetings, and journals. It found that engaging in these academic activities costs individual neurosurgeons a staggering $11,588 each year, which is significantly higher than costs in other specialties, such as $8,105 for plastic surgery and $7,013 for orthopedic surgery. This matters because the growing financial burden may be hard to sustain, especially since reimbursement for continuing education hasn't increased. Who this helps: This helps neurosurgeons by highlighting the financial challenges they face in staying engaged with their profession.

Plain English
This study looked at a genetic mutation in children that increases the risk of a type of brain tumor called medulloblastoma, particularly the Sonic hedgehog subtype. Researchers found that mice with this mutation developed pre-cancerous conditions and tumors similar to what is seen in humans with the same genetic change, and when they treated these tumors with a specific drug that blocks a protein named MDM2, it improved survival by activating a crucial tumor-suppressing pathway. These findings highlight a potential new treatment approach for children with ELP1-related medulloblastoma. Who this helps: This helps patients with ELP1-associated medulloblastoma.

Plain English
This study looked at the oil from the seeds of a plant called Salicornia brachiata to see if it could help manage diabetes and obesity. Researchers found that the oil contains a fatty acid called linoleic acid, which showed promise in lowering blood sugar and cholesterol levels in mice. Specifically, mice that received the oil showed significant reductions in blood glucose and cholesterol levels, making it a potential natural treatment for these conditions. Who this helps: This benefits patients dealing with diabetes and obesity.

Plain English
This study looked at whether adding high doses of the drug methotrexate would help young children under 36 months old with high-risk embryonal brain tumors. Out of 59 children who received treatment, 28 (47.5%) experienced complete recovery, with those getting methotrexate showing better outcomes specifically in one type of tumor called Group 3 medulloblastoma (63% complete response) compared to those who did not receive it (30% complete response). This matters because finding effective treatments for these aggressive cancers can significantly improve survival rates in young children. Who this helps: This helps young children diagnosed with high-risk brain tumors and their families.

Plain English
This study focused on improving how brain tumors are diagnosed by using a new DNA testing method. The researchers developed a tool called the Heidelberg CNS Tumor Methylation Classifier version 12.8, which can now identify 184 different types of brain tumors, up from 91 in the previous version. This means doctors can make more accurate diagnoses, achieving 95% accuracy in identifying the specific tumors. Who this helps: This helps doctors and patients by providing more precise tumor classifications, leading to better treatment decisions.

Plain English
This study looked at two treatments for a condition known as carotid web, which can lead to strokes. Researchers examined data from 71 patients who had experienced strokes or mini-strokes and found that both carotid artery stenting (CAS) and carotid endarterectomy (CEA) were effective in reducing the risk of further strokes. Specifically, only one patient (1.4%) had a recurrent stroke during nearly 15 months of follow-up, indicating that these treatments are generally safe and effective. Who this helps: Patients with carotid web who are at risk of future strokes.

Plain English
This study examines two types of medications, SGLT2 inhibitors and GLP-1 receptor agonists, that are used to treat conditions related to Cardiovascular-Kidney-Metabolic (CKM) syndrome, which includes obesity, type 2 diabetes, chronic kidney disease, and heart disease. The research highlights that when these drugs are used together, they can provide significant benefits, such as better heart function and lower blood sugar levels. The findings emphasize the importance of using both medications early in treatment to improve patient outcomes, but notes that many patients do not receive this combined therapy due to cost and accessibility issues. Who this helps: Patients with cardiovascular, kidney, and metabolic disorders.

Plain English
This study looked at a specific type of brain tumor called WNT-activated medulloblastoma, which is known for its unique features and a great outlook for patients. Researchers found that more than 90% of patients with this tumor type survive without disease progression for at least five years, and there are ongoing trials to see if lowering radiation and chemotherapy dosages can keep these good survival rates while reducing long-term side effects. Understanding these tumors better can help improve treatments and lessen the impact of therapy on patients’ lives. Who this helps: This benefits patients with WNT-activated medulloblastoma and their families.

Plain English
This research studied 164 infants with a rare brain tumor called infant-type hemispheric glioma (IHG), which is often diagnosed when they are about 3.4 months old. The study found that 86.5% of these tumors had specific gene fusions and that 79.6% of the patients survived after three years, but surgery can also lead to serious risks, including death. The results highlight the need for better treatment strategies that balance the risks of surgery with the benefits of effective tumor removal. Who this helps: This helps patients with infant-type hemispheric glioma and their families by informing treatment options.

Plain English
This study reviews a rare type of brain tumor in young children called infant-type hemispheric gliomas (IHGs), which are usually large and diagnosed in infancy. It finds that while current treatments, including surgery and chemotherapy, can help children survive, many face long-term health challenges due to complications. The research emphasizes the importance of developing better treatment strategies, especially since IHGs have unique genetic features that could make them responsive to new targeted therapies. Who this helps: Children diagnosed with infant-type hemispheric gliomas and their families.

Plain English
This study focused on finding effective treatment options for high-risk medulloblastoma, especially a challenging type known as MYC-driven Group 3 (G3) medulloblastoma. Researchers identified 32 potential drug combinations, and 19 of those worked well together in lab tests, with the combination of MEK inhibitors and regorafenib showing the best results by slowing tumor growth and improving survival rates in animal models. This is important because it could lead to better treatment strategies for patients with this aggressive form of cancer. Who this helps: This helps patients with high-risk medulloblastoma and their doctors by providing new treatment options.

Plain English
This study examined whether adding chemotherapy to radiation therapy improves survival in children diagnosed with ependymoma, a type of brain tumor. The researchers followed 449 patients and found that five-year event-free survival was 69.2% for those who received both radiation and chemotherapy, compared to 63.7% for those who received radiation alone. Overall survival rates were also similar, with 88.3% for the combination treatment and 86.9% for radiation only, showing no significant benefit from chemotherapy after radiation. Who this helps: This research benefits doctors and families of children with ependymoma by providing clearer guidelines on the effectiveness of treatment options.

Plain English
The study looked at different methods to classify brain tumors using DNA methylation profiles, which are changes to DNA that can indicate specific tumor types. Researchers developed three models—a deep learning model, k-nearest neighbor model, and random forest model—and tested them on over 2,000 tumor samples. The deep learning model outperformed the others, accurately classifying tumors even when the tumor samples had low purity, which is important for ensuring effective treatment decisions for patients. Who this helps: This benefits patients with brain tumors by providing more accurate diagnostic options.

Plain English
This study looked at how D-dimer levels, a blood marker, affect the results of a procedure called thrombectomy for treating patients with acute ischemic stroke. The findings showed that patients with low D-dimer levels had much better outcomes, with 4.4 times higher chances of a favorable recovery and over 4 times higher chances of the blood vessel reopening properly compared to those with high D-dimer levels. Understanding this relationship is important for doctors in predicting which patients are likely to have better recovery after treatment. Who this helps: This information helps doctors in treating stroke patients and improving their chances of recovery.

Plain English
This study looked at the use of Bevacizumab, a drug traditionally used for cancer treatment, to see if it could help patients with chronic subdural hematomas (cSDH), which are collections of blood on the brain. Researchers found that levels of a protein called VEGF, which promotes blood vessel growth and is linked to high recurrence rates of cSDH, were much higher in these patients than in healthy individuals. Using Bevacizumab could reduce the chance of cSDH coming back and lower the risk of serious complications like vision loss. Who this helps: Patients suffering from chronic subdural hematomas.

Plain English
This research paper focuses on brain arteriovenous malformations (AVMs), which are abnormal blood vessel connections in the brain that can lead to serious complications like rupture. The study highlights a significant finding that most sporadic brain AVMs have mutations in a specific gene called KRAS, which plays a role in their development. It suggests that targeting the KRAS/MAPK pathway with new medications could be an effective way to treat these malformations, potentially impacting many patients. Who this helps: Patients with sporadic brain AVMs.

Plain English
This study looked at how artificial intelligence (AI) is being used to improve stroke diagnosis and treatment. It reviewed 31 studies and found that tools like Viz.ai and RapidAI can accurately identify stroke types and help doctors make faster decisions, which is crucial for patient care. Specifically, these AI tools showed high accuracy in diagnosing strokes, enhancing treatment options and outcomes for patients. Who this helps: This helps patients experiencing strokes and the doctors who treat them.